Pro Share Advisors LLC Ionis Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 8,640 shares of IONS stock, worth $325,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,640
Previous 9,011 4.12%
Holding current value
$325,555
Previous $429,000 19.35%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$40.06 - $51.86 $14,862 - $19,240
-371 Reduced 4.12%
8,640 $346,000
Q2 2024

Aug 13, 2024
SELL
$36.45 - $47.7 $43,922 - $57,478
-1,205 Reduced 11.8%
9,011 $429,000
Q1 2024

May 08, 2024
BUY
$42.03 - $53.55 $44,089 - $56,173
1,049 Added 11.44%
10,216 $442,000
Q4 2023

Feb 14, 2024
SELL
$43.39 - $51.63 $8,808 - $10,480
-203 Reduced 2.17%
9,167 $463,000
Q3 2023

Nov 13, 2023
BUY
$38.5 - $47.13 $4,312 - $5,278
112 Added 1.21%
9,370 $425,000
Q2 2023

Aug 10, 2023
SELL
$34.73 - $43.33 $22,678 - $28,294
-653 Reduced 6.59%
9,258 $379,000
Q1 2023

May 11, 2023
SELL
$33.58 - $41.2 $134,051 - $164,470
-3,992 Reduced 28.71%
9,911 $354,000
Q4 2022

Feb 02, 2023
SELL
$37.12 - $46.52 $10,950 - $13,723
-295 Reduced 2.08%
13,903 $525,000
Q3 2022

Nov 04, 2022
BUY
$36.54 - $48.66 $30,364 - $40,436
831 Added 6.22%
14,198 $628,000
Q2 2022

Aug 01, 2022
SELL
$31.71 - $43.0 $143,773 - $194,962
-4,534 Reduced 25.33%
13,367 $495,000
Q1 2022

May 10, 2022
SELL
$29.88 - $37.04 $165,266 - $204,868
-5,531 Reduced 23.6%
17,901 $663,000
Q4 2021

Feb 08, 2022
SELL
$25.61 - $35.1 $257,815 - $353,351
-10,067 Reduced 30.05%
23,432 $713,000
Q3 2021

Nov 12, 2021
BUY
$33.54 - $40.55 $103,169 - $124,731
3,076 Added 10.11%
33,499 $1.12 Million
Q2 2021

Aug 13, 2021
BUY
$34.54 - $47.25 $286,267 - $391,608
8,288 Added 37.44%
30,423 $1.21 Million
Q1 2021

May 14, 2021
SELL
$42.51 - $63.78 $83,107 - $124,689
-1,955 Reduced 8.12%
22,135 $995,000
Q4 2020

Feb 09, 2021
SELL
$45.3 - $60.27 $38,006 - $50,566
-839 Reduced 3.37%
24,090 $1.36 Million
Q3 2020

Nov 13, 2020
BUY
$47.45 - $62.95 $29,419 - $39,029
620 Added 2.55%
24,929 $1.18 Million
Q2 2020

Aug 03, 2020
BUY
$46.85 - $61.05 $121,903 - $158,852
2,602 Added 11.99%
24,309 $1.43 Million
Q1 2020

May 15, 2020
SELL
$41.6 - $63.4 $489,590 - $746,154
-11,769 Reduced 35.16%
21,707 $1.03 Million
Q4 2019

Feb 12, 2020
SELL
$53.85 - $65.27 $407,321 - $493,702
-7,564 Reduced 18.43%
33,476 $2.02 Million
Q3 2019

Nov 12, 2019
SELL
$59.06 - $72.15 $197,319 - $241,053
-3,341 Reduced 7.53%
41,040 $2.46 Million
Q2 2019

Aug 13, 2019
SELL
$62.09 - $86.14 $490,945 - $681,108
-7,907 Reduced 15.12%
44,381 $2.85 Million
Q1 2019

May 15, 2019
BUY
$52.92 - $81.17 $85,359 - $130,927
1,613 Added 3.18%
52,288 $4.24 Million
Q4 2018

Feb 14, 2019
SELL
$43.37 - $59.54 $440,378 - $604,569
-10,154 Reduced 16.69%
50,675 $2.74 Million
Q3 2018

Nov 14, 2018
BUY
$42.88 - $53.7 $218,087 - $273,118
5,086 Added 9.12%
60,829 $3.14 Million
Q2 2018

Aug 13, 2018
SELL
$40.53 - $50.7 $220,321 - $275,605
-5,436 Reduced 8.89%
55,743 $2.32 Million
Q1 2018

May 14, 2018
SELL
$44.08 - $55.05 $415,189 - $518,515
-9,419 Reduced 13.34%
61,179 $2.7 Million
Q4 2017

Feb 14, 2018
SELL
$50.3 - $64.39 $121,072 - $154,986
-2,407 Reduced 3.3%
70,598 $3.55 Million
Q3 2017

Nov 13, 2017
BUY
$45.56 - $59.57 $308,669 - $403,586
6,775 Added 10.23%
73,005 $3.7 Million
Q2 2017

Aug 11, 2017
BUY
N/A
66,230
66,230 $3.37 Million

Others Institutions Holding IONS

# of Institutions
403
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email